264 related articles for article (PubMed ID: 19375846)
1. Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
Semjonow A
Eur Urol; 2010 Apr; 57(4):629-30. PubMed ID: 19375846
[No Abstract] [Full Text] [Related]
2. Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
Ciatto S
Eur Urol; 2010 Apr; 57(4):630. PubMed ID: 19375847
[No Abstract] [Full Text] [Related]
3. Comparing prediction tools.
Kattan MW
Eur Urol; 2010 Apr; 57(4):569-70; discussion 574. PubMed ID: 20080334
[No Abstract] [Full Text] [Related]
4. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Lughezzani G; Budäus L; Isbarn H; Sun M; Perrotte P; Haese A; Chun FK; Schlomm T; Steuber T; Heinzer H; Huland H; Montorsi F; Graefen M; Karakiewicz PI
Eur Urol; 2010 Apr; 57(4):562-8. PubMed ID: 20018437
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
D'Amico AV; Chen MH
J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151
[No Abstract] [Full Text] [Related]
6. Inadequacy of prostate-specific antigen doubling time estimates calculated using an ultrasensitive assay of prostate-specific antigen for biochemical failure after radical prostatectomy.
Shimizu F; Matsuyama Y; Tominaga T; Ohashi Y; Fujime M
Urol Int; 2007; 79(4):356-60. PubMed ID: 18025856
[TBL] [Abstract][Full Text] [Related]
7. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.
Chang SL; Freedland SJ; Terris MK; Aronson WJ; Kane CJ; Amling CL; Presti JC
Urology; 2010 Feb; 75(2):439-44. PubMed ID: 19819536
[TBL] [Abstract][Full Text] [Related]
8. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.
Doherty AP; Bower M; Smith GL; Miano R; Mannion EM; Mitchell H; Christmas TJ
Br J Cancer; 2000 Dec; 83(11):1432-6. PubMed ID: 11076649
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
Stenman UH
Eur Urol; 2007 Oct; 52(4):1074-5. PubMed ID: 17383813
[No Abstract] [Full Text] [Related]
10. Natural history of patients presenting biochemical recurrence after radical prostatectomy: some good news?
Guillonneau BD; Fizazi K
Eur Urol; 2011 Jun; 59(6):900-1. PubMed ID: 21419564
[No Abstract] [Full Text] [Related]
11. Editorial Comment to Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.
Viney R
Int J Urol; 2010 Nov; 17(11):922-3. PubMed ID: 20969639
[No Abstract] [Full Text] [Related]
12. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment.
Carter HB
Urology; 2009 Sep; 74(3):658; author reply 659. PubMed ID: 19716923
[No Abstract] [Full Text] [Related]
15. Investigative clinical study on prostate cancer part II: on the role of the pretreatment total PSA to free testosterone ratio as a marker assessing prostate cancer prognostic groups after radical retropubic prostatectomy.
Porcaro AB; Monaco C; Romano M; Petrozziello A; Rubilotta E; Lacola V; Sava T; Ghimenton C; Caruso B; Antoniolli SZ; Migliorini F; Comunale L
Urol Int; 2010; 85(2):152-8. PubMed ID: 20616526
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.
Boorjian SA; Thompson RH; Tollefson MK; Rangel LJ; Bergstralh EJ; Blute ML; Karnes RJ
Eur Urol; 2011 Jun; 59(6):893-9. PubMed ID: 21388736
[TBL] [Abstract][Full Text] [Related]
17. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy.
Ahove DA; Hoffman KE; Hu JC; Choueiri TK; D'Amico AV; Nguyen PL
Urology; 2010 Nov; 76(5):1201-5. PubMed ID: 20709376
[TBL] [Abstract][Full Text] [Related]
18. Personalized prediction of tumor response and cancer progression on prostate needle biopsy.
Donovan MJ; Khan FM; Fernandez G; Mesa-Tejada R; Sapir M; Zubek VB; Powell D; Fogarasi S; Vengrenyuk Y; Teverovskiy M; Segal MR; Karnes RJ; Gaffey TA; Busch C; Haggman M; Hlavcak P; Freedland SJ; Vollmer RT; Albertsen P; Costa J; Cordon-Cardo C
J Urol; 2009 Jul; 182(1):125-32. PubMed ID: 19450827
[TBL] [Abstract][Full Text] [Related]
19. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
[TBL] [Abstract][Full Text] [Related]
20. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
Koppie TM; Grossfeld GD; Nudell DM; Weinberg VK; Carroll PR
J Urol; 2001 Jul; 166(1):111-5. PubMed ID: 11435834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
